CVS Urinary Pain Relief Tablets
Phenazopyridine hydrochloride 95 mg. Fast relief for urinary discomfort. 25% more free. 40 for the price of 32. Pain. Burning. Urgency. Compare to the active ingredient in Azo Standard (This product is not manufactured or distributed by Amerifit Nutrition, Inc., owners of the registered trademark Azo Standard).
- Product Type:
- Urinary Pain Relief
- 21-30 CT
- Ship & Save:
- Ship & Save Eligible
- Urinary Tract Infection
Active Ingredient (in Each Tablet): Phenazopyridine Hydrochloride (95 mg). Inactive Ingredients: Magnesium Stearate, Microcrystalline Cellulose, May Also Contain Carnauba Wax, Croscarmellose Sodium, Hypromellose, Lactose, Magnesium Silicate, Maize Starch, Pharmaceutical Glaze, Polyethylene Glycol, Povidone, Pregelatinized Starch, Sodium Starch Glycolate.
Adults and Children 12 And over: Take 2 tablets 3 times daily with a full glass of water, with or after meals as needed. Children Under 12: Consult a doctor. Do not use for more than 2 days (12 tablets) without consulting a doctor. Store at room temperature 59-86 degrees F (15-30 degrees C) in a dry place and protect from light.
Do not exceed recommended dosage. Ask a doctor before use if you have kidney disease; allergies to foods, preservatives or dyes; had a hypersensitive reaction to phenazopyridine. When using this product stomach upset may occur, taking this product with or after meals may reduce stomach upset; your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items. Stop use and ask a doctor if your symptoms last for more than 2 days; you suspect you are having an adverse reaction to the medication. If pregnant or breast feeding, ask a health professional before use. Keep out of reach of children. In case of an overdose, get medical help or contact a Poison Control Center right away. This product may stain contact lenses. This product can interfere with laboratory tests including urine, glucose (sugar), and ketones tests. Long term administration of phenazopyridine HCl has induced neoplasia in rats (large intestine) and mice (liver). Although no association between phenazopyridine hydrochloride and human neoplasia has been reported, adequate epidemiological studies along these lines have not been conducted. Tablets sealed in cellophane. Do not use if cellophane is open or damaged.